Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers
Miguel Á. Galán, Lorena Vigón, Daniel Fuertes, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2592
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 164
Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors
Luigi di Filippo, Stefano Frara, Fabrizio Nannipieri, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 10, pp. e1106-e1116
Open Access | Times Cited: 64
Cellular and molecular biomarkers of long COVID: a scoping review
Estefanía Espín, Chengliang Yang, Casey P. Shannon, et al.
EBioMedicine (2023) Vol. 91, pp. 104552-104552
Open Access | Times Cited: 62
Long COVID: a review and proposed visualization of the complexity of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
The role of immune activation and antigen persistence in acute and long COVID
Skye Opsteen, Jacob K. Files, Tim Fram, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 5, pp. 545-562
Open Access | Times Cited: 40
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID
Manish Dhawan, Ali A. Rabaan, Sara Alwarthan, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 699-699
Open Access | Times Cited: 39
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer
Aristo Vojdani, Sadi Köksoy, Elroy Vojdani, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 230-230
Open Access | Times Cited: 19
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications
Clara Di Vito, Francesca Calcaterra, Nicolò Coianiz, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 30
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches
Valeria Conti, Graziamaria Corbi, Francesco Sabbatino, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 334-334
Open Access | Times Cited: 28
Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, et al.
Future Virology (2023) Vol. 18, Iss. 3, pp. 177-191
Open Access | Times Cited: 26
Cardiovascular autonomic dysfunction in “Long COVID”: pathophysiology, heart rate variability, and inflammatory markers
Karina Carvalho Marques, Juarez Antônio Simões Quaresma, Luiz Fábio Magno Falcão
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 25
Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies
Sarah J. Annesley, Daniel Missailidis, Benjamin Heng, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 443-458
Open Access | Times Cited: 13
Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review
Nawar Diar Bakerly, Nikki Smith, Julie Darbyshire, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 4, pp. 473-473
Open Access | Times Cited: 9
Cardiovascular effects of the post-COVID-19 condition
Erin Goerlich, Tae Hwan Chung, Gloria Hong, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 2, pp. 118-129
Open Access | Times Cited: 7
Is post-COVID syndrome an autoimmune disease?
Juan‐Manuel Anaya, María Herrán, Santiago Beltrán, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 7, pp. 653-666
Closed Access | Times Cited: 31
Divergent adaptive immune responses define two types of long COVID
Jérôme Kervevan, Isabelle Staropoli, Dorsaf Slama, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Mechanisms of long COVID: An updated review
Yan Liu, Xiaoying Gu, Haibo Li, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 4, pp. 231-240
Open Access | Times Cited: 15
CAR-NK cell therapy: a potential antiviral platform
Ming-Hao Lin, Lijuan Hu, Jeffrey S. Miller, et al.
Science Bulletin (2025)
Closed Access
Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis
Najeeha Talat Iqbal, Hana Khan, Aqsa Khalid, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
On the post-COVID syndrome pathogenesis
Nikolay Klimov, А. С. Симбирцев
Cytokines and inflammation (2025)
Closed Access
The relationship between the phenotype of long COVID symptoms and one-year psychosocial outcomes: an exploratory clustering analysis
Muneaki Hemmi, Naoki Kanda, Kensuke Nakamura, et al.
Psychology Health & Medicine (2025), pp. 1-17
Closed Access
Immunological and clinical markers of post-acute sequelae of COVID-19: Insights from mild and severe cases six months post-infection
William Mouton, Sophia Djebali, Marine Villard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Page 1 - Next Page

Scroll to top